Induction of oral tolerance in experimental Sjögren's syndrome autoimmunity

Scandinavian Journal of Immunology

Volumn 61, Issue 5, 2005, Pages 418-425

  Kurien, B T ^a   Asfa, S ^a   Li, C ^a   Dorri, Y ^a   Jonsson, R ^b   Scofield, R H ^a,c,d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; PEPTIDE; PROTEIN RO 274; PROTEIN RO 60; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; EPITOPE MAPPING; EXPERIMENTAL MODEL; FEMALE; FLOW MEASUREMENT; HYPOTHESIS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SALIVATION; SJOEGREN SYNDROME;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; AUTOANTIGENS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SERA; IMMUNE TOLERANCE; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 18844366162     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01593.x     Document Type: Article

References (49)

1. Wells H. Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of hen's egg. J Infect Dis 1911;9:147-51.
2. Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946;61:257-9.
3. Stokes CR, Miller BG, Bourne FJ. Animal models of food sensitivity. In: Brostoff J, Challacombe SJ, eds. Food Allergy and Intolerance. Eastbourne, UK: W.B. Saunders, 1987: 286-300.
4. Miller BG, Newby TJ, Stokes CR, Bourne FJ. Influence of diet on postweaning malabsorption and diarrhoea in the pig. Res Vet Sci 1984;36:187-93.
5. Bhogal BS, Karkhanis YD, Bell MK et al. Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B-cell tolerance in rabbits after feeding antigen. Cell Immunol 1986;101:93-104.
6. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663-70.
7. Harley JB, Scofield RH. Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology. J Clin Immunol 1991;11:297-316.
8. Farris AD, Gross JK, Hanas JS, Harley JB. Genes for murine Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures and are unlinked on mouse chromosome 6. Gene 1996;174:35-42.
9. O'Brien CA, Wolin SL. A possible role for the 60-kDa Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 1994;8:2891-903.
10. Yamagata H, Harley JB, Reichlin M. Molecular properties of the Ro/SSA antigen and ELISA for quantitation of antibody. J Clin Invest 1984;74:625-33.
11. Harley JB, Yamagata H, Reichlin M. Anti-La/SSB antibody is present in some normals and is coincident with anti-Ro/SSA precipitins in systemic lupus erythematosus. J Rheumatol 1984;11:309-14.
12. Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:337-58.
13. Harley JB, Sestak AS, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum 1989;32: 826-36.
14. Kurien BT, Newland JG, Paczkowski C, Moore KL, Scofield RH. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. 2000;120:209-17.
15. Fujisaku A, Frank MB, Neas B, Reichlin M, Harley JB. HLA-DQ gene complement and other histocompatibility relationships in man with the Anti-Ro/SSA autoantibody response in systemic lupus erythematosus. J Clin Invest 1989;86:606-11.
16. Frank MB, McArthur R, Harley JB, Fujisaku A. Anti-Ro (SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990;85:33-9.
17. Scofield RH, Frank MB, Neas BR et al. Cooperative association of T cell beta receptor and HLA-DQ alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopathol 1994;72:335-41.
18. Scofield RH, Dickey WD, Hardgrave KL et al. Immunogenetics of epitopes of the carboxyl terminus of the human 60-kDa Ro autoantigen. Clin Exp Immunol 1995;99:256-61.
19. Reveille JD, Ma MJ, Lcod C, Whittington K, Arnett FC. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 1991;146:3871-6.
20. Scofield RH, Harley JB. Association of anti-Ro (SS-A) autoantibodies with glutamine in position 34 of DQA1 and leucine in position 26 of DQB1. Arthritis Rheum 1994;37:961-2.
21. Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT. The immunogenetic relationship between anti-Ro (SS-A) /La (SS-B) antibody positive Sjogren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome. J Invest Dermatol 1989;93:751-6.
22. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;359:155-7.
23. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides derived from the systemic lupus erythematosus associated 60 kD Ro autoantigen results in autoimmunity directed towards the Ro ribonucleoprotein. J Immunol 1996;156:4059-66.
24. Scofield RH, Kaufman KM, Baber U, James JA, Harley JB, Kurien BT. Immunization of mouse with 60 kD Ro peptides results in epitope spreading if peptides are highly homologous between man and mouse. Arthritis Rheum 1992;42:1017-24
25. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization. Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453.
26. Bockenstedt LK, Gee RJ, Mamula MJ. Self-peptides in the initiation of lupus autoimmunity. J Immunol 1995;154:3516-24.
27. Topfer F, Gordon T, McCluskey J. Intra- and inter-molecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995;92:875-9.
28. Kawahata K, Misaki Y, Komagata Y et al. Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self. J Immunol 1999;162:6482-91.
29. Deshmukh US, Lewis JE, Gaskin F et al. Immune response to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced antibodies. J Exp Med 1999;189:531-40.
30. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172:603.
31. Billingham RE, Brent L, Medawar PB. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Proc Natl Acad Sci USA 1956;238:357.
32. Burkly LC, Lo D, Kanagawa O, Brinster RL, Flavell RA. T cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II, I-E. Nature 1989;342:564.
33. Morahan G, Allison J, Miller JF. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 1989;339:622.
34. Murakami M, Honjo T. Transgenic mouse models for B-cell dominant autoimmune diseases. Curr Opin Immunol 1997;8:846-50.
35. Boyd GW. An evaluation-based hypothesis on the origin and mechanism of autoimmune disease. Immunol Cell Biol 1997;75: 503-7.
36. Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Molec Life Sci 2000;57:542-51.
37. Bockenstedt LK, Gee RJ, Mamula MJ. Self-peptides in the initiation of lupus autoimmunity. J Immunol 1995;154:3516-24.
38. Scofield RH, Kaufman KM, Baber U, James JA, Harley JB, Kurien BT. Immunization of mouse with 60 kD Ro peptides results in epitope spreading if peptides are highly homologous between man and mouse. Arthritis Rheum 1999;42:1017-24.
39. Kroemer G, Martinez C. Mechanisms of self tolerance. Immunol Today 1992;13:401-4. (Review)
40. Miller JFAP, Moraham G. Peripheral T cell tolerance. Annu Rev Immunol 1992;10:51-70.
41. Mowat AM. The regulation of immune responses to dietary protein antigens. Immunol Today 1987;8:93-8.
42. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155-63.
43. Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-42.
44. Mowat AM, Thomas MJ, MacKenzie S, Parrott DM. Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and paniculate antigens in mice. Immunology 1986;58:677-83.
45. Mowat AM, Strobel S, Drummond HE, Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 1982;45:105-13.
46. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993;151:5751-61.
47. Weiner HL, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-37. (Review)
48. Melamed D, Fishman-Lovell J, Uni Z, Weiner HL, Friedman A. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int Immunol 1996;8:717-24.
49. Challacombe SJ, Tomasi TB Jr. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 1980;152:1459-72.